{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:00:12Z","timestamp":1794024012716,"version":"4.8.0"},"reference-count":227,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.bcp.2023.115553","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T20:21:49Z","timestamp":1681762909000},"page":"115553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Physiological and pharmacological overview of the gonadotropin releasing hormone"],"prefix":"10.1016","volume":"212","author":[{"given":"Lavinia","family":"Casati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2733-513X","authenticated-orcid":false,"given":"Roberto","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Bottai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0006-291X(71)90766-2","article-title":"Isolation and properties of the FSH and LH-releasing hormone","volume":"43","author":"Schally","year":"1971","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2023.115553_b0010","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/humupd\/dmv059","article-title":"GnRH and GnRH receptors in the pathophysiology of the human female reproductive system","volume":"22","author":"Maggi","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.bcp.2023.115553_b0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/bs.vh.2018.01.003","article-title":"GnRH in the Human Female Reproductive Axis","volume":"107","author":"Limonta","year":"2018","journal-title":"Vitam and Horm"},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrendo.2016.193","article-title":"An updated view of hypothalamic-vascular-pituitary unit function and plasticity","volume":"13","author":"Le Tissier","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1210\/er.2003-0002","article-title":"Gonadotropin-releasing hormone receptors","volume":"25","author":"Millar","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bcp.2023.115553_b0030","unstructured":"N.M. Aubead, Role of sex hormone in human body, in: C. Marsh (Ed.), Reproductive May 5th, 2021, IntechOpen, Doi: 10.5772\/intechopen. 91499."},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b0035","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1210\/jc.2009-2108","article-title":"Estrogen negative feedback on gonadotropin secretion: evidence for a direct pituitary effect in women","volume":"95","author":"Shaw","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0040","first-page":"49","article-title":"Idiopathic Central Hypogonadism Study Group of the Italian Societies of Endocrinology and Pediatric Endocrinology and Diabetes","volume":"14","author":"Bonomi","year":"2012","journal-title":"New understandings of the genetic basis of isolated idiopathic central hypogonadism, Asian J Androl"},{"key":"10.1016\/j.bcp.2023.115553_b0045","first-page":"69","article-title":"The mammalian GnRH gene and its pivotal role in reproduction","volume":"43","author":"Seeburg","year":"1987","journal-title":"Recent Prog. Horm. Res."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2023.115553_b0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.anireprosci.2005.05.032","article-title":"GnRHs and GnRH receptors","volume":"88","author":"Millar","year":"2005","journal-title":"Anim. Reprod. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0055","doi-asserted-by":"crossref","first-page":"E206","DOI":"10.1210\/jc.2012-3294","article-title":"Responsiveness to a physiological regimen of GnRH therapy and relation to genotype in women with isolated hypogonadotropic hypogonadism","volume":"98","author":"Abel","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2023.115553_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygcen.2020.113465","article-title":"Gonadotropin-releasing hormone neuron development in vertebrates","volume":"292","author":"Duan","year":"2020","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.bcp.2023.115553_b0065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ygcen.2014.07.025","article-title":"GnRH receptors and peptides: skating backward","volume":"209","author":"Roch","year":"2014","journal-title":"Gen. Comp. Endocrinol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2023.115553_b0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0303-7207(03)00076-5","article-title":"Multi-factorial role of GnRH-I and GnRH-II in the human ovary","volume":"202","author":"Leung","year":"2003","journal-title":"Mol. Cell. Endocrinol."},{"issue":"17","key":"10.1016\/j.bcp.2023.115553_b0075","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.1073\/pnas.94.17.9499","article-title":"A hypothalamic follicle-stimulating hormone-releasing decapeptide in the rat","volume":"94","author":"Yu","year":"1997","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0169-328X(99)00316-2","article-title":"Two molecular forms of gonadotropin-releasing hormone (GnRH-I and GnRH-II) are expressed by two separate populations of cells in the rhesus macaque hypothalamus","volume":"75","author":"Latimer","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"9","key":"10.1016\/j.bcp.2023.115553_b0085","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1365-2826.2004.01229.x","article-title":"Emerging functions of gonadotropin-releasing hormone II in mammalian physiology and behaviour","volume":"16","author":"Kauffman","year":"2004","journal-title":"J. Neuroendocrinol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0090","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1210\/jc.2002-021359","article-title":"Relative effect of gonadotropin-releasing hormone (GnRH)-I and GnRH-II on gonadotropin release","volume":"88","author":"Densmore","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2023.115553_b0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fendo.2012.00020","article-title":"Differential roles of GnRH-I and GnRH-ii neurons in the control of the primate reproductive axis","volume":"3","author":"Urbanski","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/molehr\/7.5.447","article-title":"Expression of the second isoform of gonadotrophin-releasing hormone (GnRH-II) in human endometrium throughout the menstrual cycle","volume":"7","author":"Cheon","year":"2001","journal-title":"Mol. Hum. Reprod."},{"issue":"8","key":"10.1016\/j.bcp.2023.115553_b0105","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/jc.2008-0127","article-title":"Gonadotropin-releasing hormones I and II induce apoptosis in human granulosa cells","volume":"93","author":"Hong","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yfrne.2007.06.002","article-title":"Diversity of actions of GnRHs mediated by ligand-induced selective signaling","volume":"29","author":"Millar","year":"2008","journal-title":"Front. Neuroendocrinol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115553_b0115","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/endo.132.3.8440174","article-title":"Primary structure and biological activity of a third gonadotropin-releasing hormone from lamprey brain","volume":"132","author":"Sower","year":"1993","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.bcp.2023.115553_b0120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/gcen.1994.1134","article-title":"Effects of lamprey gonadotropin-releasing hormone-III on steroidogenesis and spermiation in male sea lampreys","volume":"95","author":"Deragon","year":"1994","journal-title":"Gen. Comp. Endocrinol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115553_b0125","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1365-2826.2002.00828.x","article-title":"Lamprey gonadotropin hormone-releasing hormone-III has no selective follicle-stimulating hormone-releasing effect in rats","volume":"14","author":"Kovacs","year":"2002","journal-title":"J. Neuroendocrinol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2023.115553_b0130","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0303-7207(94)90087-6","article-title":"The human gonadotropin-releasing hormone (GnRH) receptor gene: cloning, genomic organization and chromosomal assignment","volume":"103","author":"Fan","year":"1994","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bcp.2023.115553_b0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0083-6729(04)69006-6","article-title":"Gonadotropin-releasing hormone receptors: structure, expression, and signaling transduction","volume":"69","author":"Kakar","year":"2004","journal-title":"Vitam. Horm."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(24)01478-9","article-title":"Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling","volume":"53","author":"Ferguson","year":"2001","journal-title":"Pharmacol. Rev."},{"issue":"12","key":"10.1016\/j.bcp.2023.115553_b0145","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1210\/endo.141.12.7813","article-title":"Desensitization and internalization of human and xenopus gonadotropin-releasing hormone receptors expressed in alphaT4 pituitary cells using recombinant adenovirus","volume":"141","author":"Hislop","year":"2000","journal-title":"Endocrinology"},{"issue":"19","key":"10.1016\/j.bcp.2023.115553_b0150","doi-asserted-by":"crossref","first-page":"11472","DOI":"10.1074\/jbc.273.19.11472","article-title":"Gonadotropin-releasing hormone receptors with intracellular carboxyl-terminal tails undergo acute desensitization of total inositol phosphate production and exhibit accelerated internalization kinetics","volume":"273","author":"Heding","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0155","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1210\/endo.141.1.7269","article-title":"The rat gonadotropin-releasing hormone receptor internalizes via a beta-arrestin-independent, but dynamin-dependent, pathway: addition of a carboxyl-terminal tail confers beta-arrestin dependency","volume":"141","author":"Heding","year":"2000","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.bcp.2023.115553_b0160","first-page":"1818","article-title":"Agonist-induced endocytosis and recycling of the gonadotropin-releasing hormone receptor: effect of beta-arrestin on internalization kinetics","volume":"12","author":"Vrecl","year":"1998","journal-title":"Mol. Endocrinol."},{"issue":"42","key":"10.1016\/j.bcp.2023.115553_b0165","doi-asserted-by":"crossref","first-page":"30146","DOI":"10.1074\/jbc.274.42.30146","article-title":"Lack of a C-terminal tail in the mammalian gonadotropin-releasing hormone receptor confers resistance to agonist-dependent phosphorylation and rapid desensitization","volume":"274","author":"Willars","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0170","doi-asserted-by":"crossref","first-page":"bqab247","DOI":"10.1210\/endocr\/bqab247","article-title":"Deletion of G\u03b1q\/11 or G\u03b1s Proteins in Gonadotropes Differentially Affects Gonadotropin Production and Secretion in Mice","volume":"163","author":"Stamatiades","year":"2022","journal-title":"Endocrinology"},{"issue":"35","key":"10.1016\/j.bcp.2023.115553_b0175","doi-asserted-by":"crossref","first-page":"32099","DOI":"10.1074\/jbc.M203639200","article-title":"Involvement of both G(q\/11) and G(s) proteins in gonadotropin-releasing hormone receptor-mediated signaling in L beta T2 cells","volume":"277","author":"Liu","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2023.115553_b0180","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0188-4409(01)00331-9","article-title":"Intracellular signaling pathways mediated by the gonadotropin-releasing hormone (GnRH) receptor","volume":"32","author":"Kraus","year":"2001","journal-title":"Arch. Med. Res."},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0185","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1210\/endo-113-5-1683","article-title":"Intracellular pathways of electron-opaque gonadotropin-releasing hormone derivatives bound by cultured gonadotropes","volume":"113","author":"Jennes","year":"1983","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.bcp.2023.115553_b0190","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0196-9781(86)90015-X","article-title":"Receptor-mediated uptake of GnRH agonist and antagonists by cultured gonadotropes: evidence for differential intracellular routing","volume":"7","author":"Jennes","year":"1986","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0195","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1210\/mend-1-2-154","article-title":"Homologous desensitization with gonadotropin-releasing hormone (GnRH) also diminishes gonadotrope responsiveness to maitotoxin: a role for the GnRH receptor-regulated calcium ion channel in mediation of cellular desensitization","volume":"1","author":"Conn","year":"1987","journal-title":"Mol. Endocrinol."},{"issue":"Pt 2","key":"10.1016\/j.bcp.2023.115553_b0200","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1042\/bj3000299","article-title":"Absence of rapid desensitization of the mouse gonadotropin-releasing hormone receptor","volume":"300","author":"Davidson","year":"1994","journal-title":"Biochem. J"},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1730001","article-title":"Signalling, cycling and desensitisation of gonadotrophin-releasing hormone receptors","volume":"173","author":"McArdle","year":"2002","journal-title":"J. Endocrinol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0210","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1074\/jbc.M008916200","article-title":"Rapid down-regulation of the type I inositol 1,4,5-trisphosphate receptor and desensitization of gonadotropin-releasing hormone-mediated Ca2+ responses in alpha T3\u20131 gonadotropes","volume":"276","author":"Willars","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0215","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1507\/endocrj.52.131","article-title":"GnRH antagonist-induced down-regulation of the mRNA expression of pituitary receptors: comparisons with GnRH agonist effects","volume":"52","author":"Murase","year":"2005","journal-title":"Endocr. J."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0220","doi-asserted-by":"crossref","first-page":"20098","DOI":"10.1038\/s41598-019-56480-1","article-title":"Divergent expression patterns of pituitary gonadotropin subunit and GnRH receptor genes to continuous GnRH in vitro and in vivo","volume":"9","author":"Janjic","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b0225","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-2002-36707","article-title":"Hypogonadotropic hypogonadism","volume":"20","author":"Silveira","year":"2002","journal-title":"Semin. Reprod. Med."},{"issue":"17","key":"10.1016\/j.bcp.2023.115553_b0230","doi-asserted-by":"crossref","first-page":"9636","DOI":"10.1073\/pnas.141048498","article-title":"A novel mammalian receptor for the evolutionarily conserved type II GnRH","volume":"98","author":"Millar","year":"2001","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b0235","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1006\/bbrc.2001.4678","article-title":"A gonadotropin-releasing hormone (GnRH) receptor specific for GnRH II in primates","volume":"282","author":"Neill","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.bcp.2023.115553_b0240","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.tem.2004.08.005","article-title":"Newly recognized GnRH receptors: function and relative role","volume":"15","author":"Neill","year":"2004","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0245","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1210\/jc.2008-1741","article-title":"Type I gonadotropin-releasing hormone receptor mediates the antiproliferative effects of GnRH-II on prostate cancer cells","volume":"94","author":"Montagnani Marelli","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0250","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3892\/ijo.2014.2730","article-title":"Oxime bond-linked daunorubicin-GnRH-III bioconjugates exert antitumor activity in castration-resistant prostate cancer cells via the type I GnRH receptor","volume":"46","author":"Montagnani Marelli","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b0255","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1095\/biolreprod.114.127324","article-title":"Gonadotropin-Releasing Hormone Type II (GnRH-II) Agonist Regulates the Motility of Human Decidual Endometrial Stromal Cells: Possible Effect on Embryo Implantation and Pregnancy","volume":"92","author":"Wu","year":"2015","journal-title":"Biol. Reprod."},{"issue":"12","key":"10.1016\/j.bcp.2023.115553_b0260","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1007\/s00018-021-03829-3","article-title":"Mechanisms underlying pre- and postnatal development of the vomeronasal organ","volume":"78","author":"Katreddi","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"21","key":"10.1016\/j.bcp.2023.115553_b0265","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1242\/dev.139444","article-title":"Development of the neurons controlling fertility in humans: new insights from 3D imaging and transparent fetal brains","volume":"143","author":"Casoni","year":"2016","journal-title":"Development"},{"key":"10.1016\/j.bcp.2023.115553_b0270","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fendo.2019.00329","article-title":"Modulation of Gonadotropin-Releasing Hormone Neuron Activity and Secretion in Mice by Non-peptide Neurotransmitters, Gasotransmitters, and Gliotransmitters","volume":"10","author":"Spergel","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.bcp.2023.115553_b0275","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000497745","article-title":"The Emerging Role of Chromatin Remodeling Factors in Female Pubertal Development","volume":"109","author":"Aylwin","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b0280","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0169-328X(89)90076-4","article-title":"Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome","volume":"6","author":"Schwanzel-Fukuda","year":"1989","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"6344","key":"10.1016\/j.bcp.2023.115553_b0285","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/353529a0","article-title":"A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules","volume":"353","author":"Franco","year":"1991","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0290","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41574-020-00436-3","article-title":"Cellular and molecular features of EDC exposure: consequences for the GnRH network","volume":"17","author":"Lopez-Rodriguez","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2023.115553_b0295","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2010.02.023","article-title":"Genetics basis for GnRH-dependent pubertal disorders in humans","volume":"324","author":"Silveira","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bcp.2023.115553_b0300","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fendo.2013.00089","article-title":"Ontogenesis of gonadotropin-releasing hormone neurons: a model for hypothalamic neuroendocrine cell development","volume":"4","author":"Stevenson","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0305","first-page":"507","article-title":"Mandatory neuropeptide-steroid signaling for the preovulatory luteinizing hormone-releasing hormone discharge","volume":"14","author":"Kalra","year":"1993","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bcp.2023.115553_b0310","article-title":"Gonadotropin-releasing hormone pulses: regulators of gonadotropin synthesis and ovulatory cycles","volume":"47","author":"Marshall","year":"1991","journal-title":"Recent Prog. Horm. Res."},{"issue":"6","key":"10.1016\/j.bcp.2023.115553_b0315","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1507\/endocrj.K09E-185","article-title":"GnRH pulsatility, the pituitary response and reproductive dysfunction","volume":"56","author":"Tsutsumi","year":"2009","journal-title":"Endocr. J."},{"key":"10.1016\/j.bcp.2023.115553_b0320","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fendo.2013.00130","article-title":"Afferent neuronal control of type-I gonadotropin releasing hormone neurons in the human","volume":"4","author":"Hrabovszky","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0325","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1210\/endo-120-1-272","article-title":"In vivo and in vitro examination of an autoregulatory mechanism for luteinizing hormone-releasing hormone","volume":"120","author":"DePaolo","year":"1987","journal-title":"Endocrinology"},{"issue":"3\u20134","key":"10.1016\/j.bcp.2023.115553_b0330","first-page":"163","article-title":"Gonadotropin pulsations across development","volume":"49","author":"Hayes","year":"1998","journal-title":"Horm. Res."},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0335","doi-asserted-by":"crossref","first-page":"1081A","DOI":"10.1210\/jcem-71-5-1081","article-title":"Clinical review 15: Management of ovulatory disorders with pulsatile gonadotropin-releasing hormone","volume":"71","author":"Martin","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4368","key":"10.1016\/j.bcp.2023.115553_b0340","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1126\/science.100883","article-title":"Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone","volume":"202","author":"Belchetz","year":"1978","journal-title":"Science"},{"issue":"4535","key":"10.1016\/j.bcp.2023.115553_b0345","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.6296998","article-title":"Homologous regulation of gonadotropin-releasing hormone receptors in cultured pituitary cells","volume":"215","author":"Loumaye","year":"1982","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.bcp.2023.115553_b0350","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1210\/endo.141.7.7543","article-title":"Regulation of human gonadotropin-releasing hormone receptor gene expression in placental cells","volume":"141","author":"Cheng","year":"2000","journal-title":"Endocrinology"},{"issue":"26","key":"10.1016\/j.bcp.2023.115553_b0355","doi-asserted-by":"crossref","first-page":"20262","DOI":"10.1074\/jbc.M110.132662","article-title":"Signaling responses to pulsatile gonadotropin-releasing hormone in LbetaT2 gonadotrope cells","volume":"285","author":"Tsutsumi","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0360","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gan079","article-title":"Conservation of mechanisms mediating gonadotrophin-releasing hormone 1 stimulation of human luteinizing hormone beta subunit transcription","volume":"15","author":"Fortin","year":"2009","journal-title":"Mol. Hum. Reprod."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0365","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1210\/en.2006-0952","article-title":"Activin and glucocorticoids synergistically activate follicle-stimulating hormone beta-subunit gene expression in the immortalized LbetaT2 gonadotrope cell line","volume":"148","author":"McGillivray","year":"2007","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.bcp.2023.115553_b0370","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1210\/jc.2010-0245","article-title":"The long-term clinical follow-up and natural history of men with adult-onset idiopathic hypogonadotropic hypogonadism","volume":"95","author":"Dwyer","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.bcp.2023.115553_b0375","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1365-2265.2009.03746.x","article-title":"What is the optimal therapy for young males with hypogonadotropic hypogonadism?","volume":"72","author":"Han","year":"2010","journal-title":"Clin. Endocrinol."},{"issue":"9","key":"10.1016\/j.bcp.2023.115553_b0380","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2174\/138955712800959080","article-title":"Gonadotropin-releasing hormone receptor signaling: biased and unbiased","volume":"12","author":"McArdle","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0385","first-page":"580","article-title":"Expression of human gonadotropin-releasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion","volume":"80","author":"Lin","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b0390","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1677\/erc.1.00777","article-title":"Gonadotropin-releasing hormone and its receptor in normal and malignant cells","volume":"11","author":"Harrison","year":"2004","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0395","first-page":"207","article-title":"Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP","volume":"75","author":"Limonta","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"15","key":"10.1016\/j.bcp.2023.115553_b0400","first-page":"4091","article-title":"Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop","volume":"54","author":"Dondi","year":"1994","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0405","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/gyno.1994.1264","article-title":"Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium","volume":"55","author":"Imai","year":"1994","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b0410","first-page":"817","article-title":"Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma","volume":"55","author":"Irmer","year":"1995","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0415","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3181\/0707-MR-201","article-title":"Luteinizing hormone-releasing hormone I (LHRH-I) and its metabolite in peripheral tissues","volume":"233","author":"Walters","year":"2008","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"1 Pt 1","key":"10.1016\/j.bcp.2023.115553_b0420","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0002-9378(13)70287-4","article-title":"Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: role of apoptosis","volume":"170","author":"Kleinman","year":"1994","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"15","key":"10.1016\/j.bcp.2023.115553_b0425","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1073\/pnas.91.15.7090","article-title":"Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75","volume":"91","author":"Yano","year":"1994","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0430","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0006-291X(02)00427-8","article-title":"Luteinizing hormone-releasing hormone induces JunD-DNA binding and extends cell cycle in human ovarian cancer cells","volume":"294","author":"Gunthert","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.bcp.2023.115553_b0435","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1210\/jc.2003-031871","article-title":"Type II gonadotropin-releasing hormone stimulates p38 mitogen-activated protein kinase and apoptosis in ovarian cancer cells","volume":"89","author":"Kim","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0440","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1210\/jcem-51-1-173","article-title":"Simulation of the normal menstrual cycle in Kallman's syndrome by pulsatile administration of luteinizing hormone-releasing hormone (LHRH)","volume":"51","author":"Crowley","year":"1980","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"21","key":"10.1016\/j.bcp.2023.115553_b0445","first-page":"2937","article-title":"Pulsatile administration of low-dose gonadotropin-releasing hormone","volume":"250","author":"Miller","year":"1983","journal-title":"Ovulation and pregnancy in women with hypothalamic amenorrhea, JAMA"},{"issue":"3","key":"10.1016\/j.bcp.2023.115553_b0450","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3171\/jns.1978.49.3.0382","article-title":"Luteinizing hormone-releasing hormone in human pituitary blood","volume":"49","author":"Antunes","year":"1978","journal-title":"J. Neurosurg."},{"issue":"6","key":"10.1016\/j.bcp.2023.115553_b0455","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0015-0282(16)54716-5","article-title":"Endocrinology of gonadotropin-releasing hormone induced cycles in hypothalamic amenorrhea: the role of the pulse dose","volume":"56","author":"Braat","year":"1991","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0460","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/jcem-72-5-965","article-title":"Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders","volume":"72","author":"Filicori","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0465","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0889-8529(18)30232-9","article-title":"Ovulation stimulation and induction","volume":"21","author":"Blacker","year":"1992","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"9","key":"10.1016\/j.bcp.2023.115553_b0470","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1056\/NEJMoa066494","article-title":"Reversal of idiopathic hypogonadotropic hypogonadism","volume":"357","author":"Raivio","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2023.115553_b0475","doi-asserted-by":"crossref","unstructured":"M.D. Scheiber, J.H. Liu, The Use of Gonadotropin-Releasing Hormone to Induce Ovulation, in: F. Peter von Dadelszen (Ed), Glob. libr. women's med, 2011.","DOI":"10.3843\/GLOWM.10340"},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0480","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1677\/joe.0.0600305","article-title":"Blood and urine clearance of luteinizing hormone releasing hormone in man measured by radioimmunoassay","volume":"60","author":"Jeffcoate","year":"1974","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0485","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1210\/edrv.18.2.0295","article-title":"Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor","volume":"18","author":"Sealfon","year":"1997","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0490","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/ncpendmet0399","article-title":"Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone","volume":"3","author":"Engel","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2023.115553_b0495","first-page":"723","article-title":"Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics","volume":"13","author":"Lahlou","year":"2000","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bcp.2023.115553_b0500","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jsxm.2016.05.004","article-title":"Efficacy and Safety of Gonadotropin-Releasing Hormone Agonist Treatment to Suppress Puberty in Gender Dysphoric Adolescents","volume":"13","author":"Schagen","year":"2016","journal-title":"J. Sex. Med."},{"issue":"7","key":"10.1016\/j.bcp.2023.115553_b0505","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1007\/s10508-020-01660-8","article-title":"Trajectories of Adolescents Treated with Gonadotropin-Releasing Hormone Analogues for Gender Dysphoria","volume":"49","author":"Brik","year":"2020","journal-title":"Arch. Sex. Behav."},{"issue":"6","key":"10.1016\/j.bcp.2023.115553_b0510","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s40618-020-01449-5","article-title":"Systematic Review: Puberty suppression with GnRH analogues in adolescents with gender incongruity","volume":"44","author":"Ramos","year":"2021","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0515","first-page":"46","article-title":"Studies of gonadotropin-releasing hormone (GnRH) action using GnRH receptor-expressing pituitary cell lines","volume":"18","author":"Kaiser","year":"1997","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0520","first-page":"80","article-title":"Pharmacokinetics of the gonadotropin-releasing hormone agonist buserelin after injection of a slow-release preparation in normal men","volume":"42","author":"Behre","year":"1992","journal-title":"Arzneimittelforschung"},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0525","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0015-0282(00)00598-7","article-title":"A crossover study of triptorelin and leuprorelin acetate","volume":"74","author":"Cheung","year":"2000","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b0530","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2265.1985.tb00144.x","article-title":"A radioimmunoassay for GnRH agonist analogue in serum of patients with prostate cancer treated with D-Ser (tBu)6 AZA Gly10 GnRH","volume":"22","author":"Clayton","year":"1985","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0535","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00003088-200039010-00003","article-title":"Clinical pharmacokinetics of goserelin","volume":"39","author":"Cockshott","year":"2000","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.bcp.2023.115553_b0540","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0028-2243(91)90121-Z","article-title":"Subcutaneous injection or infusion of gonadotropin releasing-hormone agonist buserelin in the treatment of enlarged uteri harboring leiomyomata","volume":"40","author":"Franssen","year":"1991","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0545","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/14656566.2016.1258058","article-title":"Androgen deprivation therapy with Leuprolide acetate for treatment of advanced prostate cancer","volume":"18","author":"Hoda","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0550","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12917-022-03237-0","article-title":"The pharmacokinetics of buserelin after intramuscular administration in pigs and cows","volume":"18","author":"Kong","year":"2022","journal-title":"BMC Vet. Res."},{"issue":"3","key":"10.1016\/j.bcp.2023.115553_b0555","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/1756287215577329","article-title":"Efficacy of triptorelin pamoate 11.25 mg administered subcutaneously for achieving medical castration levels of testosterone in patients with locally advanced or metastatic prostate cancer, Ther","volume":"7","author":"Lebret","year":"2015","journal-title":"Adv Urol"},{"issue":"6","key":"10.1016\/j.bcp.2023.115553_b0560","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1210\/jcem-54-6-1169","article-title":"Metabolic clearance and plasma half-disappearance time of D-TRP6 and exogenous luteinizing hormone-releasing hormone","volume":"54","author":"Barron","year":"1982","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b0565","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF03189737","article-title":"Disposition of 3H-labelled buserelin continuously infused into rats","volume":"21","author":"Heinrich","year":"1996","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"7","key":"10.1016\/j.bcp.2023.115553_b0570","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00003088-200241070-00003","article-title":"Clinical pharmacokinetics of depot leuprorelin","volume":"41","author":"Periti","year":"2002","journal-title":"Clin. Pharmacokinet."},{"issue":"17","key":"10.1016\/j.bcp.2023.115553_b0575","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1517\/14656566.2010.529900","article-title":"Triptorelin embonate: a 6-month formulation for prostate cancer","volume":"11","author":"Whelan","year":"2010","journal-title":"Expert Opin. Pharmacother."},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115306","article-title":"PEGylated leuprolide with improved pharmacokinetic properties","volume":"28","author":"Fu","year":"2020","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b0585","first-page":"1289","article-title":"Radioligand assay for gonadotropin-releasing hormone: relative potencies of agonists and antagonists","volume":"106","author":"Perrin","year":"1980","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0590","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/0006-291X(75)90851-7","article-title":"LH-releasing activity of potent LH-RH analogs in vitro","volume":"67","author":"Coy","year":"1975","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2023.115553_b0595","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/0-306-47384-4_7","article-title":"LHRH antagonists","volume":"11","author":"Haviv","year":"1998","journal-title":"Pharm. Biotechnol."},{"key":"10.1016\/j.bcp.2023.115553_b0600","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00024669-200504030-00004","article-title":"Triptorelin in the Treatment of Prostate Cancer","volume":"4","author":"Heyns","year":"2005","journal-title":"American Journal of Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0605","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/bph.13342","article-title":"Characterization of 12 GnRH peptide agonists - a kinetic perspective","volume":"173","author":"Nederpelt","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0610","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1016-8478(23)13785-X","article-title":"GnRH-II analogs for selective activation and inhibition of non-mammalian and type-II mammalian GnRH receptors","volume":"16","author":"Maiti","year":"2003","journal-title":"Mol. Cells"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2023.115553_b0615","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.anireprosci.2005.05.005","article-title":"GnRH analogues\u2013agonists and antagonists","volume":"88","author":"Padula","year":"2005","journal-title":"Anim. Reprod. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0620","first-page":"44","article-title":"Gonadotropin-releasing hormone analog design","volume":"7","author":"Karten","year":"1986","journal-title":"Structure-function studies toward the development of agonists and antagonists: rationale and perspective, Endocr Rev"},{"issue":"10","key":"10.1016\/j.bcp.2023.115553_b0625","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0196-9781(99)00130-8","article-title":"Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis","volume":"20","author":"Schally","year":"1999","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0630","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1634\/theoncologist.5-2-162","article-title":"Development of GnRH antagonists for prostate cancer: new approaches to treatment","volume":"5","author":"Cook","year":"2000","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.bcp.2023.115553_b0635","first-page":"401","article-title":"LH-RH analogues: I","volume":"13","author":"Schally","year":"1999","journal-title":"Their impact on reproductive medicine, Gynecol Endocrinol"},{"issue":"6","key":"10.1016\/j.bcp.2023.115553_b0640","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.coph.2003.06.009","article-title":"Gonadotropin-releasing hormone antagonists","volume":"3","author":"Herbst","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2023.115553_b0645","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1517\/13543770903410237","article-title":"Luteinizing hormone-releasing hormone antagonists","volume":"19","author":"Mezo","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0650","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tem.2008.09.003","article-title":"Will GnRH antagonists improve prostate cancer treatment?","volume":"20","author":"Huhtaniemi","year":"2009","journal-title":"Trends Endocrinol Metab"},{"issue":"22","key":"10.1016\/j.bcp.2023.115553_b0655","first-page":"5439","article-title":"High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines","volume":"53","author":"Emons","year":"1993","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0660","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.fertnstert.2010.08.045","article-title":"The role of peripheral gonadotropin-releasing hormone receptors in female reproduction","volume":"95","author":"Yu","year":"2011","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0665","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/humrep\/16.2.201","article-title":"Embryo implantation and GnRH antagonists: the search for the human placental GnRH receptor","volume":"16","author":"Rama","year":"2001","journal-title":"Hum. Reprod."},{"issue":"9","key":"10.1016\/j.bcp.2023.115553_b0670","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1093\/humrep\/13.9.2392","article-title":"Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers","volume":"13","author":"Duijkers","year":"1998","journal-title":"Hum. Reprod."},{"issue":"11","key":"10.1016\/j.bcp.2023.115553_b0675","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1517\/17425255.2015.1085506","article-title":"Pharmacokinetic and pharmacodynamic profile of degarelix for prostate cancer","volume":"11","author":"Klotz","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115553_b0680","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0015-0282(99)00414-8","article-title":"Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon\/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers","volume":"72","author":"Obery\u00e9","year":"1999","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b0685","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0009-9236(02)17637-5","article-title":"Pharmacokinetics and pharmacodynamics of abarelix, a gonadotropin-releasing hormone antagonist, after subcutaneous continuous infusion in patients with prostate cancer","volume":"73","author":"Wong","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b0690","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/00005392-200204000-00021","article-title":"Abarelix StudyA Group, A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer","volume":"167","author":"Trachtenberg","year":"2002","journal-title":"J. Urol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0695","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0022-5347(05)66353-7","article-title":"The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancer","volume":"165","author":"Tomera","year":"2001","journal-title":"J. Urol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0700","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0090-4295(03)00656-3","article-title":"Abarelix StudyA Group, An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists","volume":"62","author":"Koch","year":"2003","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0705","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.juro.2008.07.033","article-title":"Degarelix StudyD Group, A 1-year, open label, randomized phase II dose finding study of degarelix for the treatment of prostate cancer in North America","volume":"180","author":"Gittelman","year":"2008","journal-title":"J. Urol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115553_b0710","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1464-410X.2008.08183.x","article-title":"The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer","volume":"102","author":"Klotz","year":"2008","journal-title":"BJU Int."},{"issue":"12","key":"10.1016\/j.bcp.2023.115553_b0715","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1021\/jm701249f","article-title":"Non-peptide gonadotropin-releasing hormone receptor antagonists","volume":"51","author":"Betz","year":"2008","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2023.115553_b0720","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.3390\/molecules22122188","article-title":"Recent Development of Non-Peptide GnRH Antagonists","volume":"22","author":"Tukun","year":"2017","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.bcp.2023.115553_b0725","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1021\/jm00129a003","article-title":"LH-RH antagonists: design and synthesis of a novel series of peptidomimetics","volume":"32","author":"De","year":"1989","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/j.bcp.2023.115553_b0730","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1021\/jm8006454","volume":"51","author":"Chen","year":"2008","journal-title":"J. Med. Chem."},{"issue":"14","key":"10.1016\/j.bcp.2023.115553_b0735","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1021\/jm200216q","volume":"54","author":"Miwa","year":"2011","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2023.115553_b0740","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/1440-1681.13688","article-title":"Pharmacological characterization of linzagolix, a novel, orally active, non-peptide antagonist of gonadotropin-releasing hormone receptors","volume":"49","author":"Tezuka","year":"2022","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0745","doi-asserted-by":"crossref","first-page":"72.e1","DOI":"10.1016\/j.ajog.2020.07.032","article-title":"Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids","volume":"224","author":"Al-Hendy","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0750","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/AOG.0000000000002933","article-title":"Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial","volume":"132","author":"Carr","year":"2018","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b0755","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/14656566.2022.2030705","article-title":"An evaluation of relugolix\/estradiol\/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women","volume":"23","author":"Ali","year":"2022","journal-title":"Expert Opin. Pharmacother."},{"issue":"10356","key":"10.1016\/j.bcp.2023.115553_b0760","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(22)01475-1","article-title":"Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials","volume":"400","author":"Donnez","year":"2022","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b0765","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1007\/s43032-020-00172-z","article-title":"Effects of combined GnRH receptor antagonist linzagolix and hormonal add-back therapy on vaginal bleeding-delayed add-back onset does not improve bleeding pattern","volume":"27","author":"Pohl","year":"2020","journal-title":"Reprod. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0770","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1210\/en.2006-1213","article-title":"Pharmacological characterization of a novel nonpeptide antagonist of the human gonadotropin-releasing hormone receptor, NBI-42902","volume":"148","author":"Struthers","year":"2007","journal-title":"Endocrinology"},{"issue":"20","key":"10.1016\/j.bcp.2023.115553_b0775","doi-asserted-by":"crossref","first-page":"11854","DOI":"10.1021\/acs.jmedchem.0c01076","article-title":"Discovery and Characterization of BAY 1214784, an Orally Available Spiroindoline Derivative Acting as a Potent and Selective Antagonist of the Human Gonadotropin-Releasing Hormone Receptor as Proven in a First-In-Human Study in Postmenopausal Women","volume":"63","author":"Panknin","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2023.115553_b0780","unstructured":"S. Li, S. Ke, C. Yang, J. Chen, Y. Xiong, L. Zheng, H. Liu, L. Hong, A Ligand-and-structure Dual-driven Deep Learning Method for the Discovery of Highly Potent GnRH1R Antagonist to treat Uterine Diseases, arXiv:2207.11547 (2022)."},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0785","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1038\/s41467-020-19109-w","article-title":"Structure of the human gonadotropin-releasing hormone receptor GnRH1R reveals an unusual ligand binding mode","volume":"11","author":"Yan","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0790","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1210\/mend.14.5.0464","article-title":"Identification of Phe313 of the gonadotropin-releasing hormone (GnRH) receptor as a site critical for the binding of nonpeptide GnRH antagonists","volume":"14","author":"Cui","year":"2000","journal-title":"Mol. Endocrinol."},{"issue":"33","key":"10.1016\/j.bcp.2023.115553_b0795","doi-asserted-by":"crossref","first-page":"34115","DOI":"10.1074\/jbc.M404474200","article-title":"Species selectivity of nonpeptide antagonists of the gonadotropin-releasing hormone receptor is determined by residues in extracellular loops II and III and the amino terminus","volume":"279","author":"Reinhart","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0800","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1021\/jm0506928","article-title":"Overlapping, nonidentical binding sites of different classes of nonpeptide antagonists for the human gonadotropin-releasing hormone receptor","volume":"49","author":"Betz","year":"2006","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2023.115553_b0805","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/molehr\/gaq091","article-title":"Induced pluripotent stem cells: epigenetic memories and practical implications","volume":"16","author":"Sullivan","year":"2010","journal-title":"Mol. Hum. Reprod."},{"issue":"20","key":"10.1016\/j.bcp.2023.115553_b0810","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1021\/acs.jcim.2c00639","article-title":"Discovery of Small Molecule Agonist of Gonadotropin-Releasing Hormone Receptor (GnRH1R)","volume":"62","author":"Yang","year":"2022","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.bcp.2023.115553_b0815","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s40262-019-00840-7","article-title":"Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis","volume":"59","author":"Shebley","year":"2020","journal-title":"Clin. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.bcp.2023.115553_b0820","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1210\/jc.2015-2770","article-title":"Medical Castration Using the Investigational Oral GnRH Antagonist TAK-385 (Relugolix): Phase 1 Study in Healthy Males","volume":"100","author":"MacLean","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.bcp.2023.115553_b0825","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s40265-022-01753-9","article-title":"Linzagolix: First Approval","volume":"82","author":"Keam","year":"2022","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0830","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/bcp.15171","article-title":"A model-based analysis to guide gonadotropin-releasing hormone receptor antagonist use for management of endometriosis","volume":"88","author":"Pohl","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0835","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1210\/jc.2017-01875","article-title":"Gonadotropin-Releasing Hormone Receptor Antagonist Mono- and Combination Therapy With Estradiol\/Norethindrone Acetate Add-Back: Pharmacodynamics and Safety of OBE2109","volume":"103","author":"Pohl","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"14","key":"10.1016\/j.bcp.2023.115553_b0840","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s40265-018-0977-4","article-title":"Elagolix: First Global Approval","volume":"78","author":"Lamb","year":"2018","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b0845","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.fertnstert.2020.02.114","article-title":"Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial","volume":"114","author":"Donnez","year":"2020","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.bcp.2023.115553_b0850","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40265-019-01105-0","article-title":"Relugolix: First Global Approval","volume":"79","author":"Markham","year":"2019","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.bcp.2023.115553_b0855","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJMoa2008283","article-title":"Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy","volume":"384","author":"Al-Hendy","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0860","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.fertnstert.2020.07.055","article-title":"Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose-response manner: a randomized, double-blind, placebo-controlled study","volume":"115","author":"Osuga","year":"2021","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0865","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0015-0282(16)45850-4","article-title":"Induction of ovulation and pregnancy with pulsatile luteinizing hormone releasing factor: dosage and mode of delivery","volume":"36","author":"Reid","year":"1981","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.bcp.2023.115553_b0870","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/ana.410340603","article-title":"Molecular genetics in neurology","volume":"34","author":"Martin","year":"1993","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0875","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b0880","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.fertnstert.2015.01.012","article-title":"Introduction: Gonadotropin-releasing hormone agonist triggering of final follicular maturation for in vitro fertilization","volume":"103","author":"Casper","year":"2015","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.bcp.2023.115553_b0885","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1210\/en.2014-1803","article-title":"Classical and membrane-initiated estrogen signaling in an in vitro model of anterior hypothalamic kisspeptin neurons","volume":"156","author":"Mittelman-Smith","year":"2015","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.bcp.2023.115553_b0890","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/humupd\/8.3.279","article-title":"The use of GnRH antagonists in ovarian stimulation","volume":"8","author":"Olivennes","year":"2002","journal-title":"Hum. Reprod. Update"},{"issue":"27","key":"10.1016\/j.bcp.2023.115553_b0895","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1097\/MD.0000000000000260","article-title":"Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis","volume":"93","author":"Li","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.bcp.2023.115553_b0900","first-page":"306","article-title":"Review of outcomes after cessation of gonadotropin-releasing hormone agonist treatment of girls with precocious puberty","volume":"11","author":"Thornton","year":"2014","journal-title":"Pediatr. Endocrinol. Rev."},{"issue":"8","key":"10.1016\/j.bcp.2023.115553_b0905","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrendo.2013.120","article-title":"Current and future applications of GnRH, kisspeptin and neurokinin B analogues","volume":"9","author":"Millar","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b0910","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/GCO.0000000000000084","article-title":"Novel agents for the medical treatment of endometriosis","volume":"26","author":"Platteeuw","year":"2014","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.bcp.2023.115553_b0915","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/191967","article-title":"Medical treatments for endometriosis-associated pelvic pain","volume":"2014","author":"Zito","year":"2014","journal-title":"Biomed Res. Int."},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0920","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1210\/er.2012-1014","article-title":"GnRH Receptors in Cancer: From Cell Biology to Novel Targeted Therapeutic Strategies","volume":"33","author":"Limonta","year":"2012","journal-title":"Endocr. Rev."},{"issue":"11","key":"10.1016\/j.bcp.2023.115553_b0925","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1093\/humrep\/deq240","article-title":"Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma","volume":"25","author":"Khan","year":"2010","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0930","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ejogrb.2013.08.010","article-title":"Regression of the inflammatory microenvironment of the peritoneal cavity in women with endometriosis by GnRHa treatment","volume":"170","author":"Nirgianakis","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.bcp.2023.115553_b0935","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fendo.2017.00187","article-title":"The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis","volume":"8","author":"Gr\u00fcndker","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.bcp.2023.115553_b0940","doi-asserted-by":"crossref","unstructured":"SGO Clinical Practice Endometrial Cancer Working Group, W.M. Burke, J. Orr, M. Leitao, E. Salom, P. Gehrig, A.B. Olawaiye, M. Brewer, D. Boruta, J. Villella, T. Herzog, F. Abu Shahin, Society of Gynecologic Oncology Clinical Practice Committee, Endometrial cancer: a review and current management strategies: part I, Gynecol Oncol 134(2) (2014) 385-92.","DOI":"10.1016\/j.ygyno.2014.05.018"},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b0945","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.bcp.2023.115553_b0950","first-page":"2059","article-title":"The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor","volume":"56","author":"Chatzaki","year":"1996","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0955","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/gyno.1997.4746","article-title":"Involvement of annexin V in antiproliferative effects of gonadotropin-releasing hormone agonists on human endometrial cancer cell line","volume":"66","author":"Shibata","year":"1997","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b0960","first-page":"1223","article-title":"GnRH-II agonist [D-Lys6]GnRH-II inhibits the EGF-induced mitogenic signal transduction in human endometrial and ovarian cancer cells","volume":"29","author":"Eicke","year":"2006","journal-title":"Int. J. Oncol."},{"issue":"16","key":"10.1016\/j.bcp.2023.115553_b0965","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1158\/0008-5472.CAN-08-4657","article-title":"GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax","volume":"69","author":"Fister","year":"2009","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b0970","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of Prostate Cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"issue":"24","key":"10.1016\/j.bcp.2023.115553_b0975","doi-asserted-by":"crossref","first-page":"9511","DOI":"10.3390\/ijms21249511","article-title":"Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions","volume":"21","author":"Fontana","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2023.115553_b0980","first-page":"CD012548","article-title":"Degarelix for treating advanced hormone-sensitive prostate cancer","volume":"8","author":"Zengerling","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bcp.2023.115553_b0985","doi-asserted-by":"crossref","DOI":"10.1177\/1758835921998586","article-title":"Relugolix: a novel androgen deprivation therapy for management of patients with advanced prostate cancer","volume":"13","author":"Saad","year":"2021","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.bcp.2023.115553_b0990","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3389\/fonc.2019.00943","article-title":"Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs","volume":"9","author":"Huerta-Reyes","year":"2019","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115553_b0995","doi-asserted-by":"crossref","first-page":"e99723","DOI":"10.1371\/journal.pone.0099723","article-title":"Apoptotic death of prostate cancer cells by a gonadotropin-releasing hormone-II antagonist","volume":"9","author":"Park","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2023.115553_b1000","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fendo.2019.00370","article-title":"The Anti-proliferative Activity of GnRH Through Downregulation of the Akt\/ERK Pathways in Pancreatic Cancer","volume":"10","author":"Suo","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b1005","first-page":"1277","article-title":"Novel insights into GnRH receptor activity: role in the control of human glioblastoma cell proliferation","volume":"21","author":"Montagnani Marelli","year":"2009","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2023.115553_b1010","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1517\/13543784.2012.685128","article-title":"AEZS-108: a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors","volume":"21","author":"Engel","year":"2012","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b1015","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/cells10020437","article-title":"Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer","volume":"10","author":"Gr\u00fcndker","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b1020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3390\/cells10020292","article-title":"The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial Cancer","volume":"10","author":"Emons","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.bcp.2023.115553_b1025","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ctrv.2012.12.003","article-title":"Gonadotropin-releasing hormone receptors as molecular therapeutic targets in prostate cancer: Current options and emerging strategies","volume":"39","author":"Limonta","year":"2013","journal-title":"Cancer Treat. Rev."},{"issue":"20","key":"10.1016\/j.bcp.2023.115553_b1030","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.4161\/cc.26358","article-title":"Ovarian follicle burnout: a universal phenomenon?","volume":"12","author":"Roness","year":"2013","journal-title":"Cell Cycle"},{"issue":"9","key":"10.1016\/j.bcp.2023.115553_b1035","first-page":"1044","article-title":"How to preserve fertility in young women exposed to chemotherapy?","volume":"12","author":"Blumenfeld","year":"2007","journal-title":"The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries, Oncologist"},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b1040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0974-1208.153119","article-title":"Fertility preservation in female cancer patients: An overview","volume":"8","author":"Mahajan","year":"2015","journal-title":"J Hum Reprod Sci"},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b1045","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10815-015-0428-z","article-title":"Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience","volume":"32","author":"Cardozo","year":"2015","journal-title":"J. Assist. Reprod. Genet."},{"issue":"7","key":"10.1016\/j.bcp.2023.115553_b1050","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1517\/14656566.2015.1031654","article-title":"Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists","volume":"16","author":"Blumenfeld","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"issue":"3","key":"10.1016\/j.bcp.2023.115553_b1055","first-page":"CD008018","article-title":"Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women","volume":"3","author":"Chen","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bcp.2023.115553_b1060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.yhbeh.2015.05.010","article-title":"Luteinizing hormone as a key player in the cognitive decline of Alzheimer's disease","volume":"76","author":"Burnham","year":"2015","journal-title":"Horm. Behav."},{"issue":"9","key":"10.1016\/j.bcp.2023.115553_b1065","first-page":"1992","article-title":"Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies","volume":"53","author":"Andersen","year":"1999","journal-title":"EURODEM Incidence Research Group, Neurology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115553_b1070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrn3856","article-title":"The neuroprotective actions of oestradiol and oestrogen receptors","volume":"16","author":"Arevalo","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b1075","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1083\/jcb.200707043","article-title":"Gonadotropin-releasing hormone regulates spine density via its regulatory role in hippocampal estrogen synthesis","volume":"180","author":"Prange-Kiel","year":"2008","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b1080","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1471-4159.2009.06502.x","article-title":"Down-regulation of serum gonadotropins is as effective as estrogen replacement at improving menopause-associated cognitive deficits","volume":"112","author":"Bryan","year":"2010","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.bcp.2023.115553_b1085","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/jnnp-2017-316015","article-title":"Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study","volume":"88","author":"Hashizume","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"10.1016\/j.bcp.2023.115553_b1090","first-page":"671","article-title":"Progressive proximal spinal and bulbar muscular atrophy of late onset","volume":"18","author":"Kennedy","year":"1968","journal-title":"A sex-linked recessive trait, Neurology"},{"issue":"5","key":"10.1016\/j.bcp.2023.115553_b1095","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00415-019-09251-x","article-title":"J.s. group, Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials","volume":"266","author":"Hashizume","year":"2019","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115553_b1100","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.4103\/1673-5374.170311","article-title":"Leuprolide acetate induces structural and functional recovery of injured spinal cord in rats","volume":"10","author":"D\u00edaz Galindo","year":"2015","journal-title":"Neural Regen. Res."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b1105","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10620-019-05783-4","article-title":"Leuprolide Acetate, a GnRH Agonist, Improves the Neurogenic Bowel in Ovariectomized Rats with Spinal Cord Injury","volume":"65","author":"Altamira-Camacho","year":"2020","journal-title":"Dig. Dis. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b1110","doi-asserted-by":"crossref","first-page":"352","DOI":"10.21307\/ane-2018-034","article-title":"Neurological improvement in patients with chronic spinal cord injury treated with leuprolide acetate, an agonist of GnRH","volume":"78","author":"Quintanar","year":"2018","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"issue":"10","key":"10.1016\/j.bcp.2023.115553_b1115","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1007\/s11064-012-0842-x","article-title":"Leuprolide acetate, a GnRH agonist, improves experimental autoimmune encephalomyelitis: a possible therapy for multiple sclerosis","volume":"37","author":"Guzm\u00e1n-Soto","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bcp.2023.115553_b1120","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420936166","article-title":"Sex effects across the lifespan in women with multiple sclerosis","volume":"13","author":"Krysko","year":"2020","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"23","key":"10.1016\/j.bcp.2023.115553_b1125","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.2169\/internalmedicine.4839-20","article-title":"Severe Multiple Sclerosis Manifesting upon GnRH Agonist Therapy for Uterine Fibroids","volume":"59","author":"Sakurai","year":"2020","journal-title":"Intern. Med."},{"issue":"4","key":"10.1016\/j.bcp.2023.115553_b1130","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1210\/er.2016-1007","article-title":"Estrogens, Neuroinflammation, and Neurodegeneration","volume":"37","author":"Villa","year":"2016","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.bcp.2023.115553_b1135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/medicina56020049","article-title":"Pregnancy and Multiple Sclerosis: An Update on the Disease Modifying Treatment Strategy and a Review of Pregnancy's Impact on Disease Activity","volume":"56","author":"Varyt\u0117","year":"2020","journal-title":"Medicina (Kaunas)"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223001442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223001442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T04:53:31Z","timestamp":1736312011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223001442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":227,"alternative-id":["S0006295223001442"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115553","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physiological and pharmacological overview of the gonadotropin releasing hormone","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115553","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115553"}}